Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
18.07.2025 06:45:15
|
HBM Healthcare Investments publishes Quarterly Report for the period ending 30 June 2025
HBM Healthcare Investments AG / Key word(s): Quarter Results
Quarterly result affected by unfavourable currency developments In the first three months of the 2025/2026 financial year, the value of the HBM Healthcare Investments portfolio increased by 0.5 percent in investment currencies. However, the strong appreciation of the Swiss franc against the investment currencies (USD -10.3 %, CNY -9.2 %, INR -10.7 %, EUR -2.3 %) reduced performance by 8.9 percent in reporting currency. Overall, the net asset value per share (NAV) declined by 8.4 percent, resulting in a quarterly loss of CHF 140 million. The share price fell by 5.5 percent.
Developments in the portfolio of public companies Public companies lost a total of CHF 79 million in value following unfavourable currency movements totalling CHF 83 million. Operationally, many companies performed well and published significant study results:
Developments in the portfolio of private companies Private companies recorded a positive quarterly result in investment currency terms. Unfavourable currency effects totalling CHF 40 million resulted in an impairment of CHF 33 million overall.
Following unfavourable currency movements of CHF 18 million, the balance sheet value of the funds’ portfolio decreased by a total of CHF 15 million.
Asset allocation and currency profile No new investments were made during the quarter under review. CHF 7 million was invested into existing portfolio companies as follow-on financing. As a result, the asset allocation has hardly changed since the start of the financial year. Private companies account for 33 percent of total assets. Public companies account for 48 percent. More than half of these were formerly private companies (26 percent). Funds account for 10 percent, cash and cash equivalents for 5 percent, and other assets for 4 percent. Due to the portfolio’s currency profile – 53 percent in US dollars, 17 percent in euros, 12 percent in renminbi, 8 percent in Indian rupees and 2 percent each in Hong Kong dollars and Swedish kronor – HBM Healthcare Investments remains exposed to currency fluctuations.
Outlook The market environment is likely to remain uncertain, with geopolitical tensions, trade tariffs, discussions about drug price regulation, and currency fluctuations continuing to influence market sentiment and contribute to increased volatility. Despite this challenging environment, HBM Healthcare Investments expects positive outcomes from its portfolio. Private companies are expected to continue making operational progress, achieving clinical milestones, and carrying out strategic transactions. Following a subdued first half, M&A momentum is anticipated to pick up over the remainder of the year. For public companies, HBM Healthcare anticipates several relevant study results and significant regulatory decisions during the financial year. More information is available in the investor presentation on the Company’s website. HBM Healthcare Investments remains disciplined, focusing on selective investments with long-term value potential.
The Quarterly Report June 2025 is available on the Company’s website at www.hbmhealthcare.com/en/investors/financial-reports. Contact End of Inside Information |
Language: | English |
Company: | HBM Healthcare Investments AG |
Bundesplatz 1 | |
6300 Zug | |
Switzerland | |
Phone: | +41438887171 |
Fax: | +41438887172 |
E-mail: | info@hbmhealthcare.com |
Internet: | https://www.hbmhealthcare.com |
ISIN: | CH0012627250 |
Valor: | 1262725 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 2171466 |
End of Announcement | EQS News Service |
|
2171466 18-Jul-2025 CET/CEST
Nachrichten zu HBM Healthcare Investments AG
18.07.25 |
HBM Healthcare-Aktie gibt nach: HBM Healthcare rutscht im ersten Quartal tief ins Minus (AWP) | |
18.07.25 |
HBM Healthcare Investments publiziert Quartalsbericht per 30. Juni 2025 (EQS Group) | |
18.07.25 |
HBM Healthcare Investments publishes Quarterly Report for the period ending 30 June 2025 (EQS Group) | |
16.07.25 |
Key Figures 15.07.2025 (EQS Group) | |
02.07.25 |
HBM Healthcare-Aktie höher: HBM Healthcare Investments startet neues Aktienrückkaufprogramm (AWP) | |
02.07.25 |
HBM Healthcare Investments startet ein neues Aktienrückkaufprogramm (EQS Group) | |
02.07.25 |
HBM Healthcare Investments launches new share buyback programme (EQS Group) | |
01.07.25 |
Key Figures 30.06.2025 (EQS Group) |
Analysen zu HBM Healthcare Investments AG
3 Knaller-Aktien 📈im BX Musterportfolio: Quanta Services, Commerzbank & Broadcom mit François Bloch
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ Quanta Services
✅ Commerzbank
✅ Broadcom
Pünktlich zum Börsenstart diskutieren Investment-Stratege François Bloch und Börsen-Experte David Kunz oder Olivia Hähnel über ausgewählte Top-Aktienwerte aus dem BX Musterportfolio.
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Handelsoptimismus bleibt vor EZB-Leitzinsentscheid: SMI verliert leicht -- DAX im Plus -- Asiens Börsen letztlich höher - Nikkei 225 schliesst erneut deutlich stärkerDer heimische Aktienmarkt bewegt sich am Donnerstag etwas tiefer, während der deutsche Aktienmarkt klar zulegen kann. Die wichtigsten asiatischen Indizes verbuchten am Donnerstag Gewinne.
finanzen.net News
Datum | Titel |
---|---|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |